STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Electromed Stock Price, News & Analysis

ELMD NYSE

Welcome to our dedicated page for Electromed news (Ticker: ELMD), a resource for investors and traders seeking the latest updates and insights on Electromed stock.

Electromed Inc. (ELMD) specializes in advanced airway clearance solutions through its clinically validated SmartVest system. This dedicated news hub provides investors and healthcare stakeholders with essential updates on respiratory care innovations, regulatory compliance, and corporate developments.

Find authoritative coverage of ELMD's progress in HFCWO technology, including product enhancements, partnership announcements, and quality certifications. Our curated news selection emphasizes factual reporting on clinical trial outcomes and market expansion initiatives within the medical device sector.

Regular updates include earnings disclosures, manufacturing quality milestones, and research collaborations. Bookmark this resource for streamlined access to verified ELMD developments that impact respiratory therapy standards and investment considerations.

Rhea-AI Summary

Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, has announced its upcoming financial results release and conference call for the fourth quarter of fiscal 2024. The company will issue its financial results press release on August 27, 2024, after the stock market closes. Management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.

Interested parties can participate in the call by dialing (877) 407-0789 (Domestic) or (201) 689-8562 (International). A live webcast will be accessible on Electromed's website in the Investor Relations section. For those unable to listen live, a replay will be available by phone and online.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.48%
Tags
conferences earnings
-
Rhea-AI Summary

Electromed, a leader in innovative airway clearance technologies, announced its participation in the Canaccord Genuity 44th Annual Global Growth Conference in Boston from August 13-15, 2024. Jim Cunniff, President and CEO, and Brad Nagel, CFO, will present on Wednesday, August 14, 2024, at 2:30 p.m. Eastern Time.

The presentation will be available via live and archived webcast on Electromed's website under Events & Presentations. Additionally, Electromed has published an updated investor presentation deck for review, accessible on their website and the SEC website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary

Electromed, known for its innovative airway clearance technologies, announced that its top executives, President and CEO Jim Cunniff and CFO Brad Nagel, will attend the 2024 Sidoti June Small-Cap Virtual Conference. This event is scheduled for June 12-13, 2024. Electromed will present at 1:45 p.m. ET on June 12, 2024. A live and archived webcast of their presentation will be accessible via the Electromed website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.46%
Tags
conferences
Rhea-AI Summary

Electromed, Inc. achieves record revenue in the third quarter of fiscal year 2024, with a 15% increase to $13.9 million compared to the prior year. Operating income rises by 54%, net income reaches $1.49 million, and cash balance grows to $11.7 million. The company's direct homecare business revenue increases by 12%, showing strong growth and operational efficiency. The gross profit margin remains stable at 75%. Electromed continues to focus on driving adoption of its products, enhancing shareholder value, and sustaining operating leverage for profitability.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.46%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.26%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.35%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.8%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
26.92%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.28%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.18%
Tags
partnership

FAQ

What is the current stock price of Electromed (ELMD)?

The current stock price of Electromed (ELMD) is $25.26 as of November 5, 2025.

What is the market cap of Electromed (ELMD)?

The market cap of Electromed (ELMD) is approximately 208.8M.
Electromed

NYSE:ELMD

ELMD Rankings

ELMD Stock Data

208.82M
6.62M
21.3%
53.31%
3.37%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
NEW PRAGUE